LaVoieHealthScience (LHS), an integrated investor and public relations agency focused on advancing health and science innovations, announced two additional public company clients, Integrity Applications and Savara Pharmaceuticals. These clients join a prestigious group of innovative health and science companies that are represented by LHS for their investor and/or public relations solutions.
Integrity Applications, founded in 2001 and is focused on the design, development, and commercialization of non-invasive glucose monitoring technologies for people with type 2 diabetes and prediabetes. T
Savara Pharmaceuticals, went public through a reverse merger with Mast Therapeutics in 2017. Based in West Lake Hills, TX, Savara is an emerging pharmaceutical development company focused on advancing a pipeline of novel inhalation therapies for the treatment of patients with rare pulmonary conditions.
“Our integrated public and investor relations offerings, building on our team’s expertise is validated by these new client wins,” said Donna L. LaVoie, President & CEO of LaVoieHealthScience. “Each client has very specific business objectives in which our industry-tested strategic communications programs are being implemented. Aligning with true innovators in the health and science field is our passion.”